Esperion Therapeutics
·Active·New
Entry
2026
Hold
New
Status
Active
Who owns Esperion Therapeutics?
Esperion Therapeutics is currently owned by ARCHIMED through MED Platform II (2022 vintage), since 2026.
Hand-verified · updated 2026-05-07
More from MED Platform II
Other portfolio companies in the same fund.
US
ItalyTrack Esperion Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Esperion Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue